Axsome Therapeutics to Participate in Investor Conferences in September
Axsome Therapeutics (NASDAQ: AXSM), a biopharmaceutical company focused on central nervous system (CNS) disorders, has announced its participation in four major investor conferences in September 2024: 1.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Axsome Therapeutics (NASDAQ: AXSM), a biopharmaceutical company focused on central nervous system (CNS) disorders, has announced its participation in four major investor conferences in September 2024:
1. Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York (presentation at 4:50 p.m. ET)
2. Wells Fargo Healthcare Conference on September 5 in Boston (investor meetings)
3. Baird 2024 Global Healthcare Conference on September 11 in New York (presentation at 8:30 a.m. ET)
4. Cantor Global Healthcare Conference on September 18 in New York (presentation at 9:45 a.m. ET)
Live webcasts of the presentations at the Morgan Stanley and Cantor conferences will be available on Axsome's website, with replays accessible for approximately 30 days after each event.
Details
News Market Reaction – AXSM
The recorded move for AXSM in the trading session of this news was +0.47%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York
Wells Fargo Healthcare Conference on September 5 in Boston
Baird 2024 Global Healthcare Conference on September 11 in New York
Cantor Global Healthcare Conference on September 18 in New York
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will participate in four investor conferences in September:
- Morgan Stanley 22nd Annual Global Healthcare Conference
The Company will present on Wednesday, September 4, 2024 at 4:50 p.m. ET in New York, NY
- 2024 Wells Fargo Healthcare Conference
The Company will participate in investor meetings on Thursday, September 5, 2024 in Boston, MA
- Baird 2024 Global Healthcare Conference
The Company will present on Wednesday, September 11, 2024 at 8:30 a.m. ET in New York, NY
- 2024 Cantor Global Healthcare Conference
The Company will present on Wednesday, September 18, 2024 at 9:45 a.m. ET in New York, NY
Live webcasts of the presentations at the Morgan Stanley and Cantor conferences can be accessed on the Investors page of the Company’s website at www.axsome.com. Replays of the webcasts will be available for approximately 30 days following each event.
About Axsome Therapeutics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. For more information, please visit the Company’s website at www.axsome.com.
Investors:
Mark Jacobson
Chief Operating Officer
(212) 332-3243
mjacobson@axsome.com
Media:
Darren Opland
Director, Corporate Communications
(929) 837-1065
dopland@axsome.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.